Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung Cancer.

已完结 10 由 wuyaran 发布于 2024/10/15 10:56:36

DOI:10.1200/JCO.23.01488
作者：Arielle Elkrief,?Meagan Montesion,?Smruthy Sivakumar,?Caryn Hale,?Anita S Bowman,?Ayyüce Begüm Bekta?,?Martina Bradic,?Wenfei Kang,?Eric Chan,?Pooja Gogia,?Katia Manova-Todorova,?Douglas A Mata,?Jac
文献类型：期刊论文
补充材料：只需要正文

American Society of Clinical Oncology (ASCO)

Abstract：PURPOSEThe impact of the intratumoral microbiome on immune checkpoint inhibitor (ICI) efficacy in patients with non-small-cell lung cancer (NSCLC) is unknown. Preclinically, intratumoral Esc

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Royal Society of Chemistry (RSC)Regioselective synthesis of 3-nitroindoles under non-acidic and non-metallic conditions?